These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25279292)

  • 21. [Efficacy and Safety of Scalp Cooling Device RV21-01 for Suppression of Chemotherapy-Induced Alopecia in Breast Cancer Patients].
    Nomizu T; Ueo H; Kato M; Fukuma E
    Gan To Kagaku Ryoho; 2023 Mar; 50(3):321-325. PubMed ID: 36927900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
    Ridderheim M; Bjurberg M; Gustavsson A
    Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
    Chan A; Bauwens A; Pontre S; Jackson S; McGlone F; Ernenwein T; Chih J; Reid C
    Breast; 2018 Oct; 41():127-132. PubMed ID: 30048865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
    Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
    Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
    Munzone E; Bagnardi V; Campennì G; Mazzocco K; Pagan E; Tramacere A; Masiero M; Iorfida M; Mazza M; Montagna E; Cancello G; Bianco N; Palazzo A; Cardillo A; Dellapasqua S; Sangalli C; Pettini G; Pravettoni G; Colleoni M; Veronesi P
    Br J Cancer; 2019 Aug; 121(4):325-331. PubMed ID: 31303642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
    Pedersini R; Fornaro C; di Mauro P; Bianchi S; Vassalli L; Amoroso V; Gelmi M; Ardine M; Rodella F; Cosentini D; Dalla Volta A; Turla A; Pierini M; Motta P; Conti E; Simoncini EL; Berruti A
    Int J Nurs Pract; 2021 Jun; 27(3):e12888. PubMed ID: 32959460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany.
    Keim S; Hempel L; Ebner F; Retzer-Lidl M; Wohlmuth K; Hempel D; Milani V
    Oncol Res Treat; 2022; 45(7-8):395-399. PubMed ID: 35220298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
    Mols F; van den Hurk CJ; Vingerhoets AJ; Breed WP
    Support Care Cancer; 2009 Feb; 17(2):181-9. PubMed ID: 18560904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres.
    Chan J; Adderley H; Alameddine M; Armstrong A; Arundell D; Fox R; Harries M; Lim J; Salih Z; Tetlow C; Wong H; Thorp N
    Eur J Cancer Care (Engl); 2021 May; 30(3):e13395. PubMed ID: 33350015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study.
    Gianotti E; Razzini G; Bini M; Crivellaro C; Righi A; Darecchio S; Lui S; Basiricò ML; Cocconi S; Cagossi K; Ferrari A; Artioli F
    Asia Pac J Oncol Nurs; 2019; 6(3):277-282. PubMed ID: 31259224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
    Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
    Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.
    Tollenaar RA; Liefers GJ; Repelaer van Driel OJ; van de Velde CJ
    Eur J Cancer; 1994; 30A(10):1448-53. PubMed ID: 7833100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
    Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
    Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients.
    Bitto FF; König A; Phan-Brehm T; Vallbracht T; Koch JG; Schinköthe T; Wolfgarten M; Mahner S; Harbeck N; Würstlein R
    Breast Care (Basel); 2020 Apr; 15(2):171-177. PubMed ID: 32398986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia.
    van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
    Acta Oncol; 2014 Jan; 53(1):80-7. PubMed ID: 24059270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scalp hypothermia to reduce chemotherapy-induced alopecia: A systematic review and meta-analysis.
    Lambert KA; Albright BB; Anastasio MK; Kaplan SJ; McNally L
    Gynecol Oncol; 2024 Sep; 188():71-80. PubMed ID: 38936283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature.
    Komen MMC; Smorenburg CH; Nortier JWR; van der Ploeg T; van den Hurk CJG; van der Hoeven JJM
    Breast; 2016 Dec; 30():105-110. PubMed ID: 27689316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia.
    Orlando L; Loparco D; Fedele P; Schiavone P; Quaranta A; Caliolo C; Cinefra M; Rizzo P; Calvani N; Morleo A; Varriano R; Bonuso V; Falcone LL; Caloro M; Cinieri S
    Future Oncol; 2019 Oct; 15(29):3337-3344. PubMed ID: 31578891
    [No Abstract]   [Full Text] [Related]  

  • 40. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry.
    van den Hurk CJ; Peerbooms M; van de Poll-Franse LV; Nortier JW; Coebergh JW; Breed WP
    Acta Oncol; 2012 Apr; 51(4):497-504. PubMed ID: 22304489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.